Literature DB >> 19535812

B-cell-depleting induction therapy and acute cellular rejection.

Menna R Clatworthy, Christopher J E Watson, Gemma Plotnek, Vicky Bardsley, Afzal N Chaudhry, J Andrew Bradley, Kenneth G C Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19535812      PMCID： PMC4143588          DOI： 10.1056/NEJMc0808481

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

Authors:  Takashi Matsushita; Koichi Yanaba; Jean-David Bouaziz; Manabu Fujimoto; Thomas F Tedder
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

2.  Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

Authors:  F Vincenti; R Kirkman; S Light; G Bumgardner; M Pescovitz; P Halloran; J Neylan; A Wilkinson; H Ekberg; R Gaston; L Backman; J Burdick
Journal:  N Engl J Med       Date:  1998-01-15       Impact factor: 91.245

Review 3.  "To B or not to B?" B-cells and graft rejection.

Authors:  Valeriya Zarkhin; Li Li; Minnie Sarwal
Journal:  Transplantation       Date:  2008-06-27       Impact factor: 4.939

4.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Authors:  Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

5.  Rituximab, anti-CD20, induces in vivo cytokine release but does not impair ex vivo T-cell responses.

Authors:  Avinash Agarwal; Carlos A Vieira; Benita K Book; Richard A Sidner; N S Fineberg; Mark D Pescovitz
Journal:  Am J Transplant       Date:  2004-08       Impact factor: 8.086
  5 in total
  86 in total

1.  Indications of rituximab in autoimmune diseases.

Authors:  Iñaki Sanz
Journal:  Drug Discov Today Ther Strateg       Date:  2009-04-01

Review 2.  B cells as therapeutic targets in SLE.

Authors:  Iñaki Sanz; F Eun-Hyung Lee
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

Review 3.  Antibody immunosuppressive therapy in solid organ transplant: Part II.

Authors:  Dusko Klipa; Nadim Mahmud; Nasimul Ahsan
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

Review 4.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

5.  Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.

Authors:  Girdhari Lal; Yumi Nakayama; Apoorva Sethi; Amit K Singh; Bryna E Burrell; Neeraja Kulkarni; C Colin Brinkman; Daiki Iwami; Tianshu Zhang; Jonathan S Bromberg
Journal:  Transplantation       Date:  2015-09       Impact factor: 4.939

6.  Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.

Authors:  Jean Kwun; Marie Matignon; Miriam Manook; Soulef Guendouz; Vincent Audard; David Kheav; Elsa Poullot; Chantal Gautreau; Brian Ezekian; Diane Bodez; Thibault Damy; Laureline Faivre; Dehbia Menouch; Janghoon Yoon; Jaeberm Park; Karim Belhadj; Dongfeng Chen; Alyssa M Bilewski; John S Yi; Bradley Collins; Mark Stegall; Alton B Farris; Stuart Knechtle; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2019-06-21       Impact factor: 10.121

Review 7.  Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection.

Authors:  Anita S Chong; David M Rothstein; Kassem Safa; Leonardo V Riella
Journal:  Am J Transplant       Date:  2019-04-10       Impact factor: 8.086

Review 8.  Lymphodepletional strategies in transplantation.

Authors:  Eugenia Page; Jean Kwun; Byoungchol Oh; Stuart Knechtle
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

Review 9.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

10.  CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.

Authors:  Katayoun Ayasoufi; Ran Fan; Robert L Fairchild; Anna Valujskikh
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.